The Pennant Group, Inc.
HealthcareNASDAQ:PNTG · NASDAQ Global Select
+$0.07 today
Vol 0.32M · Avg 0.25M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $4.9M |
| Receivables | $122.8M |
| Other Current | $25.1M |
| Total Current Assets | $152.8M |
| PP&E (Net) | $337.2M |
| Goodwill | $237.2M |
| Intangible Assets | $199.4M |
| Tax Assets | $54.0K |
| Other Non-current | $29.8M |
| Total Non-current Assets | $803.7M |
| Total Assets | $956.5M |
Analysis
Selected assets total $956.5M for Latest. The largest visible component is PP&E (Net) at $337.2M, about 35.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.0M -29.8% | $24.2M +300.2% | $6.1M +191.4% | $2.1M -59.9% | $5.2M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $123.1M +51.4% | $81.3M +33.0% | $61.1M +14.4% | $53.4M -1.0% | $53.9M | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $27.3M +57.6% | $17.3M +34.1% | $12.9M -29.6% | $18.3M +9.6% | $16.7M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $167.4M +36.3% | $122.9M +53.4% | $80.1M +8.5% | $73.8M -2.7% | $75.8M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $336.9M +7.3% | $313.9M +7.7% | $291.5M +1.4% | $287.5M -9.5% | $317.8M | $1.2B | $1.5B | $687.8M |
| Goodwill | $237.2M +83.7% | $129.1M +41.9% | $91.0M +14.5% | $79.5M +7.0% | $74.3M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $199.4M +107.4% | $96.2M +42.0% | $67.7M +15.6% | $58.6M +9.1% | $53.7M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $478.0K | $0 | $0 -100.0% | $2.1M -44.2% | $3.8M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $26.7M +52.6% | $17.5M +87.2% | $9.3M -11.5% | $10.5M +118.4% | $4.8M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $800.8M +43.9% | $556.7M +21.1% | $459.6M +4.9% | $438.3M -3.6% | $454.5M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $968.2M +42.5% | $679.5M +25.9% | $539.7M +5.4% | $512.1M -3.4% | $530.3M | $13.3B | $11.9B | $10.6B |
| Account Payables | $25.2M +34.3% | $18.7M +72.8% | $10.8M -20.6% | $13.6M +29.3% | $10.6M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $30.0M | $0 | $0 | $0 | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $1.0M -18.1% | $1.3M +22.2% | $1.0M -6.8% | $1.1M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 -100.0% | $2.3M +37.8% | $1.7M +4.1% | $1.6M -79.2% | $7.7M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $92.1M +12961.0% | $705.0K -94.8% | $13.7M +824.4% | $1.5M -89.3% | $13.8M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $147.3M +44.8% | $101.7M +42.1% | $71.5M +1.9% | $70.2M -1.9% | $71.6M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $423.1M | $0 -100.0% | $63.9M +1.6% | $62.9M +22.4% | $51.4M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $150.0K -91.9% | $1.9M +0.3% | $1.9M | $0 -100.0% | $88.2M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 +100.0% | -$88.2M | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $23.4M +120.9% | $10.6M +28.0% | $8.3M +31.5% | $6.3M +18.7% | $5.3M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $446.7M +68.0% | $265.9M -17.6% | $322.6M +2.0% | $316.2M -8.2% | $344.4M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $593.9M +61.6% | $367.6M -6.8% | $394.2M +2.0% | $386.5M -7.1% | $416.1M | $14.7B | $3.7B | $9.6B |
| Common Stock | $35.0K +0.0% | $35.0K +20.7% | $29.0K +0.0% | $29.0K +3.6% | $28.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $86.8M +51.7% | $57.2M +65.1% | $34.7M +62.9% | $21.3M +45.4% | $14.6M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $245.8M | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $41.6M +122.9% | $18.7M +260.9% | $5.2M +11.4% | $4.6M +14.8% | $4.0M | $1.4B | $337.8M | $931.4M |
| Total Equity | $374.3M +20.0% | $312.0M +114.4% | $145.5M +15.8% | $125.7M +10.0% | $114.2M | $9.1B | $7.7B | $3.3B |
| Total Debt | $453.2M +65.9% | $273.1M -17.2% | $329.6M +0.9% | $326.6M -8.1% | $355.2M | $724.2M | $410.6M | $399.4M |
| Net Debt | $436.1M +75.3% | $248.8M -23.1% | $323.6M -0.3% | $324.5M -7.3% | $350.1M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Integra LifeSciences Holdings Corporation
NASDAQ:IART
$1.38B
InnovAge Holding Corp.
NASDAQ:INNV
$1.24B
AMN Healthcare Services, Inc.
NYSE:AMN
$1.19B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.19B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.09B
Kura Oncology, Inc.
NASDAQ:KURA
$803.41M
HealthStream, Inc.
NASDAQ:HSTM
$763.39M
Sonida Senior Living, Inc.
NYSE:SNDA
$700.96M
CorMedix Inc.
NASDAQ:CRMD
$685.67M
ProKidney Corp.
NASDAQ:PROK
$242.99M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does PNTG have?
The Pennant Group, Inc. (PNTG) reported $17.02M in cash and equivalents in fiscal 2025.
How much debt does PNTG carry?
The Pennant Group, Inc. (PNTG) reported $453.16M of total debt, with net debt of $436.14M.
Explore More
Continue the stock analysis
Jump to another research area for this company.